Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Horizons in Cancer Research -

Horizons in Cancer Research

Volume 77

Hiroto S. Watanabe (Herausgeber)

Buch | Hardcover
230 Seiten
2020
Nova Science Publishers Inc (Verlag)
978-1-5361-8717-5 (ISBN)
CHF 379,95 inkl. MwSt
  • Versand in 15-20 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
In this compilation, an overview of recent achievements in clinical and biosensor technology in the diagnosis of acute lymphoblastic leukemia is provided. Various aptasensors such as optical, electrochemical and mass-sensitive are presented along with a novel approach for the recognition of cancer markers by molecular imaging methods based on atomic force microscopy, single molecule force spectroscopy and topography and recognition imaging. The authors review the strategies used to screen potential antimelanoma drugs, especially those involved in evaluating drugs in cancer cell lines, in vitro and in vivo, as well as in silico tests used for drug selection. Following this, a study is presented focusing on gastroenteropancreatic carcinoids tumors, rare slow-growing lesions that derive from primitive stem cells of the gut. The authors explore the influence of Traditional Formosan medicine on cancer therapy through a literature review and expert opinion. Three clinical experiences of using Formosan medicine for cancer therapy are discussed: acupuncture, herb, and Formosan medicine tongue diagnosis. The concluding research utilizes the extensive pipelines of the Vienna RNA package for 2D RNA structure prediction, and the result exposes a satisfactory illustration and narration of the predicted RNA structures.

Preface; Advances in Diagnosis of Leukemia by Aptamer Based Biosensors; Melanoma Cell Lines as a Model for High-Throughput Drug Screening; Current Practices and Advances in Diagnosis and Management of Gastroenteropancreatic Carcinoid Tumors in Chil-dren; Traditional Formosan Medicine on Cancer Therapy in 21st Century; Structural Bioinformatics Approach for the Molecular Models of mir-135b and Its Silencer as Triple Negative Breast Cancer (TNBC) Biomarkers; Index.

Erscheinungsdatum
Verlagsort New York
Sprache englisch
Maße 155 x 230 mm
Gewicht 472 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Onkologie
ISBN-10 1-5361-8717-8 / 1536187178
ISBN-13 978-1-5361-8717-5 / 9781536187175
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Hannes Leischner

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
CHF 37,80
Resilienz innovativ stärken : ein Praxishandbuch

von Christa Diegelmann; Margarete Isermann; Tanja Zimmermann

Buch | Softcover (2023)
Kohlhammer (Verlag)
CHF 49,95